Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pueraria Mirifica for Lipid Parameters in Postmenopausal Women
NCT06220266Phase 3Recruiting
- Sponsor
- Dhurakij Pundit University
- Start
- Mar 2024
- Primary completion
- Aug 2024
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by Dhurakij Pundit University. Primary endpoint: Serum lipid parameters (Triglyceride, Total Cholesterol, LDL, HDL) at 2 months. Started Mar 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06220266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06220266.